Shelly Bolotin

Shelly’s research activities relate to a sero-epidemiology program to estimate population immunity to vaccine-preventable diseases, including: A study to determine whether Canada meets the level of population immunity required for measles elimination, identify groups at higher risk of measles outbreaks and predict risk of future outbreaks or epidemics. A study to determine whether Canada’s level of population immunity to varicella (chickenpox) is sufficient to prevent large outbreaks. A study to determine the level of population immunity to mumps, and to assess whether Canada is at risk of future outbreaks due to waning vaccine-mediated immunity, and a study to investigate the duration of maternal protection from measles in infants in measles elimination settings such as Canada in order to characterize the susceptibility gap between the time at which infants lose maternal antibody protection and vaccination.